Active Conferences
P22106- 09 (New Orleans, LA)
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies
Release at:
22 September 2023
P23002-02 - Northern NJ
Northern NJ 09/21/2023 - Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
21 September 2023
P23002-01 - Northern NJ
Northern NJ 09/14/2023 - Community Collective: Harnessing the Power of the Community to Battle Obesity
Release at:
14 September 2023
P23029-01 (SOHO ISS)
Pacing the Continuum of Follicular Lymphoma: Integrating Prognostic Tools and Novel Treatment Approaches
Release at:
08 September 2023
P23018-05 - IASP 2023
A Practical Approach to Skin Biopsy - From Acquisition to Analysis
Release at:
08 September 2023
P23018-01 - IASP 2023
NeuPSIG 2023 International Congress on Neuropathic Pain
Release at:
07 September 2023
P23018-04 - IASP 2023
Comprehensive Assessment of Neuropathic Pain: Neurological Exam and Quantitative Sensory Testing Hands-on Workshop
Release at:
07 September 2023
P23003-01 (SOHO)
The Society of Hematologic Oncology 2023 Eleventh Annual Meeting
Release at:
06 September 2023
P22064-09 Monongahela
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Part I: Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
28 August 2023
P2064-16- Staten Island- Part 2
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies
Release at:
10 August 2023
P22064-06 Staten Island
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
27 July 2023
P22066-10 (Wauwatosa)
Biomarker-based Therapy for NSCLC: Improving Collaboration, Communication, and Care
Release at:
19 July 2023
P22104-06
Pain and Opioids in Early Life: Long-Term Consequences for Pain Sensitivity and Neurodevelopment
Release at:
19 July 2023
P22064-15-Miami
Making the Right Call: Biomarker Testing and Targeting in NSCLC: Treating Acquired Resistance and Evaluating Next-generation Therapies (Part 2)
Release at:
10 July 2023
P22064-05-Miami
Making the Right Call: Biomarker Testing and Targeting in NSCLC Equitable, Guideline-based Testing for Prognosis and Treatment
Release at:
23 June 2023
P23021-01
Transforming Relapsed/Refractory MCL: Exploring New Options for Your Patients (ICML 2023)
Release at:
13 June 2023
P22106-15-Sibley Part 2
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice
Release at:
08 May 2023
Medical Learning Institute, Inc.
40946 US Highway 19N, #602
Tarpon Springs, FL, 34689
888.654.2631 (toll-free)
609.333.1693 (direct)
Copyright © 2023 Medical Learning Institute, Inc. All Rights Reserved.